COLUMBUS, Ohio – An Ohio State University oncologist has won a Junior Faculty Award from the Cancer and Leukemia Group B Foundation.
Dr. Kristie Blum (43017), a specialist in leukemia and lymphoma at The Ohio State University Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, is one of two physicians selected this year to receive the honor.
Kristie A. Blum, M.D
The award gives Blum $40,000 per year for the next two years to support her research.
Blum received her medical degree from the University of Miami School of Medicine and completed an internship and residency in internal medicine at the University of Virginia. She completed fellowships in hematology and oncology at Vanderbilt and Washington University before joining the faculty at Ohio State in 2003.
She is a member of the American Society of Clinical Oncology, the American Society of Hematology and the Cancer and Leukemia Group B.
Blum’s scientific work focuses on identifying and testing new anticancer drugs. She is a co-investigator on several major cancer center grants examining new therapeutic strategies in leukemia and lymphoma and most recently received a grant from the National Cancer Institute to study molecular changes involved in chronic lymphocytic leukemia.
The Junior Faculty Award is sponsored by Novartis Oncology, and is given to young physicians who demonstrate outstanding achievement during the earliest years of their career.
Blum is the second oncologist from OSU to win the award. Dr. Guido Marcucci, a member of The Ohio State University Comprehensive Cancer Center’s Molecular Biology and Cancer Genetic Program, won the first CALGB Junior Faculty Award in 2003.
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute is one of the nation’s leading centers for research on the prevention, detection, diagnosis and treatment of cancer. The OSU CCC-James encompasses six interdisciplinary research programs and includes more than 200 investigators who generate over $95 million annually in external funding. It is a founding member of the National Comprehensive Cancer Network, and The James is ranked by U.S. News & World Report as one of America’s best cancer hospitals.# # #
Medical Center Communications